To evaluate whether targeting NOTCH3 restores chemosensitivity of resistant NPC cells, we analyzed the chemo-sensitizing properties of Notch signaling inhibitor in paclitaxel resistant NPC cell line. The gene discussed is NOTCH3; the disease is nasopharyngeal carcinoma.